| Product Code: ETC13156084 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Primary Angle-Closure Glaucoma Market was valued at USD 1.2 Billion in 2024 and is expected to reach USD 1.6 Billion by 2031, growing at a compound annual growth rate of 4.80% during the forecast period (2025-2031).
The Global Primary Angle-Closure Glaucoma Market is experiencing growth due to increasing awareness about eye health, aging populations, and advancements in diagnostic technologies. Primary angle-closure glaucoma is a serious eye condition characterized by a sudden increase in intraocular pressure, leading to optic nerve damage and vision loss if left untreated. Market growth is driven by the rising prevalence of primary angle-closure glaucoma worldwide, particularly in Asia where the condition is more common. Key players in the market are focusing on developing innovative treatment options and expanding their product portfolios to cater to the growing patient population. Additionally, collaborations between pharmaceutical companies and healthcare providers are helping to improve access to diagnosis and treatment, further fueling market expansion.
The Global Primary Angle-Closure Glaucoma Market is witnessing significant growth due to the increasing prevalence of glaucoma worldwide. Technological advancements in diagnostic tools and treatment options are driving market expansion. The market is also benefiting from growing awareness about the condition among healthcare professionals and patients, leading to early detection and intervention. Additionally, the rising geriatric population and the increasing adoption of minimally invasive surgical procedures are creating opportunities for market growth. Collaborations between pharmaceutical companies, research institutions, and healthcare providers are further fueling innovation in the development of novel therapies for primary angle-closure glaucoma. Overall, the market presents a promising outlook for stakeholders looking to invest in this space.
The Global Primary Angle-Closure Glaucoma Market faces several challenges, including limited awareness and understanding of the condition among patients and healthcare professionals, leading to underdiagnosis and undertreatment. Additionally, access to proper diagnostic tools and treatments can be limited in certain regions, especially in developing countries. The high cost of medications and surgical interventions for angle-closure glaucoma can also be a significant barrier to care for patients, impacting treatment adherence and outcomes. Furthermore, the lack of standardized guidelines for the management of angle-closure glaucoma can result in variability in treatment approaches and suboptimal patient care. Overall, addressing these challenges will require concerted efforts from healthcare providers, policymakers, and pharmaceutical companies to improve access to diagnosis, treatment, and education for patients with primary angle-closure glaucoma.
The Global Primary Angle-Closure Glaucoma Market is primarily driven by factors such as the rising prevalence of glaucoma, increasing geriatric population, advancements in diagnostic technologies, and growing awareness about eye health. The expanding healthcare infrastructure in developing countries, along with the availability of effective treatment options, is also contributing to market growth. Furthermore, the rising adoption of minimally invasive surgical procedures and the development of innovative medications for glaucoma management are driving market expansion. Government initiatives to promote early diagnosis and treatment of primary angle-closure glaucoma, along with the increasing research and development activities in the ophthalmic sector, are expected to further propel market growth in the coming years.
Government policies related to the Global Primary Angle-Closure Glaucoma Market focus on improving access to diagnostic tools, treatments, and healthcare services for patients. Many governments have implemented initiatives to increase awareness about glaucoma, promote regular eye screenings, and provide financial assistance for treatment costs. Additionally, regulatory bodies have established guidelines for the approval and monitoring of glaucoma medications and devices to ensure safety and efficacy. Some governments also incentivize research and development in the field of glaucoma treatment through funding and grants. Overall, government policies aim to address the growing burden of primary angle-closure glaucoma by supporting efforts to enhance early detection, improve patient outcomes, and reduce the economic impact of the disease on healthcare systems.
The Global Primary Angle-Closure Glaucoma Market is expected to witness steady growth in the coming years, driven by increasing awareness about the condition, a growing aging population, and advancements in treatment options. The market is likely to benefit from the development of innovative therapies, such as minimally invasive surgeries and novel drug formulations, which are aimed at improving patient outcomes and quality of life. Additionally, rising healthcare expenditure and improving access to healthcare services in emerging economies are anticipated to further propel market growth. However, challenges such as high treatment costs, limited availability of healthcare facilities in rural areas, and stringent regulatory requirements may hinder market expansion to some extent. Overall, the primary angle-closure glaucoma market is poised for growth, with opportunities for companies to address unmet medical needs and enhance patient care.
In the Global Primary Angle-Closure Glaucoma market, Asia is expected to witness significant growth due to the high prevalence of the condition in countries like China and India. North America is projected to hold a substantial market share, driven by advanced healthcare infrastructure and increasing awareness about glaucoma. Europe is also anticipated to have a notable market presence, fueled by rising geriatric population and technological advancements in glaucoma treatment. In the Middle East and Africa region, the market is likely to experience steady growth due to improving healthcare facilities and growing investments in ophthalmic care. Latin America is expected to show moderate growth, with increasing government initiatives for early diagnosis and treatment of glaucoma contributing to market expansion in the region.
Global Primary Angle-Closure Glaucoma Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Primary Angle-Closure Glaucoma Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Primary Angle-Closure Glaucoma Market Revenues & Volume, 2021 & 2031F |
3.3 Global Primary Angle-Closure Glaucoma Market - Industry Life Cycle |
3.4 Global Primary Angle-Closure Glaucoma Market - Porter's Five Forces |
3.5 Global Primary Angle-Closure Glaucoma Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Primary Angle-Closure Glaucoma Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.7 Global Primary Angle-Closure Glaucoma Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Global Primary Angle-Closure Glaucoma Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Primary Angle-Closure Glaucoma Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Primary Angle-Closure Glaucoma Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Primary Angle-Closure Glaucoma Market Trends |
6 Global Primary Angle-Closure Glaucoma Market, 2021 - 2031 |
6.1 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Acute Angle-Closure Glaucoma, 2021 - 2031 |
6.1.3 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Chronic Angle-Closure Glaucoma, 2021 - 2031 |
6.2 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Diagnosis, 2021 - 2031 |
6.2.3 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Treatment, 2021 - 2031 |
6.3 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Specialty Clinics, 2021 - 2031 |
6.3.4 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.3.5 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Others, 2021 - 2031 |
6.4 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Direct Tender, 2021 - 2031 |
6.4.3 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Retail Sales, 2021 - 2031 |
6.4.4 Global Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Primary Angle-Closure Glaucoma Market, Overview & Analysis |
7.1 North America Primary Angle-Closure Glaucoma Market Revenues & Volume, 2021 - 2031 |
7.2 North America Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 North America Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Type, 2021 - 2031 |
7.5 North America Primary Angle-Closure Glaucoma Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Primary Angle-Closure Glaucoma Market, Overview & Analysis |
8.1 Latin America (LATAM) Primary Angle-Closure Glaucoma Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
8.4 Latin America (LATAM) Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Type, 2021 - 2031 |
8.5 Latin America (LATAM) Primary Angle-Closure Glaucoma Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Primary Angle-Closure Glaucoma Market, Overview & Analysis |
9.1 Asia Primary Angle-Closure Glaucoma Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
9.4 Asia Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Type, 2021 - 2031 |
9.5 Asia Primary Angle-Closure Glaucoma Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Primary Angle-Closure Glaucoma Market, Overview & Analysis |
10.1 Africa Primary Angle-Closure Glaucoma Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
10.4 Africa Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Type, 2021 - 2031 |
10.5 Africa Primary Angle-Closure Glaucoma Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Primary Angle-Closure Glaucoma Market, Overview & Analysis |
11.1 Europe Primary Angle-Closure Glaucoma Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
11.4 Europe Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Type, 2021 - 2031 |
11.5 Europe Primary Angle-Closure Glaucoma Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Primary Angle-Closure Glaucoma Market, Overview & Analysis |
12.1 Middle East Primary Angle-Closure Glaucoma Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Primary Angle-Closure Glaucoma Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
12.4 Middle East Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Type, 2021 - 2031 |
12.5 Middle East Primary Angle-Closure Glaucoma Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Primary Angle-Closure Glaucoma Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Primary Angle-Closure Glaucoma Market Key Performance Indicators |
14 Global Primary Angle-Closure Glaucoma Market - Export/Import By Countries Assessment |
15 Global Primary Angle-Closure Glaucoma Market - Opportunity Assessment |
15.1 Global Primary Angle-Closure Glaucoma Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Primary Angle-Closure Glaucoma Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
15.3 Global Primary Angle-Closure Glaucoma Market Opportunity Assessment, By Type, 2021 & 2031F |
15.4 Global Primary Angle-Closure Glaucoma Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Primary Angle-Closure Glaucoma Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Primary Angle-Closure Glaucoma Market - Competitive Landscape |
16.1 Global Primary Angle-Closure Glaucoma Market Revenue Share, By Companies, 2024 |
16.2 Global Primary Angle-Closure Glaucoma Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here